BioTech/Drugs - N/A, N/A, us
Laboratory General Manager: High Throughput In Vitro Assay Automation For Covid-xx & Other Diseases
The Revlar Labs approach to infectious disease diagnostics stands to disrupt the commercial and laboratory markets. Diagnostic efforts include Covid-targeted assays using patented biosensors in vitro, alongside on-site and Point of Care diagnostic solutions.Bypass the challenges associated with typical PCR and rapid antigen tests for COVID. Revlar Labs has designed a better diagnostic solution offering speed, simplicity and sensitivity with the ability for labs to scale accurate, rapid-results tests.CLIA LAB solutions includingHinged Peptid molecular nanoswitchesCovid-targeted assay developmentHigh-Throughput Lab (HTL) kitsON-SITE COVID SOLUTIONS for Point of Care providersVenuesEmployers School CampusesCONTACTTony@Revlarlabs.com
Outlook
Varnish
Wix
Google Cloud Hosting
Mobile Friendly